Meta Pixel

News and Announcements

Atomo Diagnostics – CEO Interview

  • Published October 27, 2015 6:09PM UTC
  • Publisher Wholesale Investor
  • Categories Executive Interviews

Atomo Diagnostics is a multi-award winning and rapidly growing medical device company that has developed and commercialised AtomoRapid™, the world’s first integrated device for blood based immunoassay rapid diagnostic testing (RDTs) in point of care settings.

Atomo launched its first test on the platform, AtomoRapid HIV, in 2014. Since launch, AtomoRapid tests have quickly established themselves as a “best in class” solution for professional use diagnostic screening.

With tests now commercialised for HIV and malaria and a rapid Ebola test ready for launch later this year, Atomo is disrupting global RDT markets where convenience, usability and safety have for many years been largely overlooked.

Please listen to John Kelly, CEO of Atomo Diagnostics below.

Company Updates
The A$20.4 Million Inertia Trap: How Kepa Software Is Unlocking Value in Enterprise Capital Allocation

A government agency renewed the same maintenance decision nine years running, because auditing the original choice was deemed too expensive. When the portfolio was finally tested, A$20.4 million of low value spend was identified in a single year. Kepa Software’s capital governance platform was built to expose and eliminate precisely these boardroom blind spots. For […]

Company Updates
The prefab company that deliberately leaves part of the house unbuilt

BuiltQuik prefabricates the floor and roof structure and stops there. Co-founder Ryan Mullaney argues the omission is the product. Prefabricated housing usually means a factory. A large central facility, identical modules, limited room to move on design, and a logistics problem getting the finished box to site. BuiltQuik builds the opposite, and the design decision […]

Join over 45,000+ sophisticated investors

Join Now